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Interventional Neuroradiology: Henry Ford Hospital Experience
with Ttanscatheter Embolization of Vascular Lesions in the Head,
Neck, and Spine
Bharat A. Mehta, MD,* Clifford R. Jack, Jr, MD,* Roushdy S. Boulos, MD, PhD,'
Suresh C. Patel, MD,* James I. Ausman, MD, PhD,^ and Ghaus M. Malik, MD^

Innovative developments over the past 15 years have resulted in increased sophistication and
effectiveness of therapeutic neuroembolization procedures. As a result, percutaneous transcatheter
embolization has assumed an increasingly important role in the management ofpatients with vascular
lesions of the head, neck, and spine. By reducing bleeding during surgery, this technique can
markedly facilitate the surgical approach to difficult vascular lesions. The technique may also be
applied in cases where surgery is contraindicated.
Therapeutic neuroembolization has been performed in 23 patients with vascular lesions of the head,
neck, or spine at Henry Ford Hospital. Devascularization ofthe extraaxial blood supply was achieved
in all cases, and no neurologic complications were encountered. Eighteen patients with vascular
tumors ofthe head, neck, or spine and three patients with arteriovenous malformations (AVM) were
embolized preoperatively, resulting in markedfacilitation ofthe surgical procedures. One patient with
a dural AVM and one with a spinal metastasis were embolized without surgery. (Henry Ford Hosp Med
J 1986;34:19-30)

T

ranscatheter embolization procedures have assumed an increasingly important role in the management of vascular lesions ofthe head, neck, and spine in recent years. A variety of
innovative developments over the past 25 years have fueled the
rapid development of neuroembolization techniques.
In the 1960s, Luessenhop (1) pioneered the injection of silastic spheres into the intemal carotid artery (ICA) to embolize
intracranial arteriovenous malformations (AVM). Embolization
of the exti-aaxial blood supply of head, neck, and spine lesions
was reported by several groups in the early 1970s (2,3). New
vascular occlusive agents directed primarily at the extraaxial
blood supply of head and neck vascular lesions as well as
vascular spinal cord lesions were developed in the late 1970s
and early 1980s. These include microspheres, autologous
clot, Gelfoam, polyvinyl alcohol sponge (PVA), collagen,
lypophihzed dura, and liquid polymers (3-7).
Improvements in catheter delivery system technology as well
as a more fliorough understanding of both the vascular anatomy
and the pathophysiology of head, neck, and spine lesions have
resulted in the increasingly wide applicability of neuroembolization procedures (3,7-11). The development of digital subtraction angiography (DSA) in the 1970s and the cunent widespread availability of this technology represents a significant
step forward.
Neuroembolization therapy is a rapidly changing field with
many areas of active research. Modemti-eatmentof many vascular lesions of the head, neck, and spine crosses many medical
disciplines. This necessitates close communication between the
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referring clinician, neuroradiologist, and various specialists,
particularly the neurosurgeon, otolaryngologist, neurologist,
plastic surgeon, radiation therapist, and oncologist. It is important for clinicians to be aware of developments in this field because select patients serve to benefit greatiy from the application
of these techniques.
This paper discusses only the neuroembolization procedures
performed at Henry Ford Hospital. Our nonembolization interventional neuroradiologic procedures are discussed in a separate
paper (12). Goals, risks, and techniques for effective neuroembolization are also discussed.

Patients, Methods, and Results
Embolization technique
Technical considerations in therapeutic embolization of vascular tumors and AVMs are nearly identical. A diagnostic angiogram must be obtained before consideration of a therapeutic
embolization procedure. The angiogram is reviewed, and a specific therapeutic approach is developed by the team of specialists, including the neuroangiographer, caring for the patient.
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The patient is admitted to the hospital the evening before the
therapeutic embolic procedure. At that time the neuroangiographer wUl outline for the patient and family the technical
considerations of the procedure, the risks, benefits, and goals.

The therapeutic procedure is performed with the parient
awake, under mild sedation and mild analgesia. The procedure
is done by introducing a thin-walled nontapered angiographic
catheter, usually via the transfemoral approach, into branches of
the extemal carotid artery (ECA). Beginning with the largest,
the individual arterial branches supplying the lesion are superselectively catheterized, then embolized. Embolization is performed by careful hand injection of a slurry, which is a mixture
of embolic particles, heparinized saline, and x-ray contrast material. The injection is done underfluoroscopicmonitoring to
prevent reflux ofthe sluny into proximal arteries supplying normal tissue. The ideal end point is defined by obliteration of the
abnormal capillary vascular stain in the lesion while preserving
flie integrity of the main feeding arteries. Frequent test (DSA)
rans are obtained to evaluate the approach to the end point.
Case material and results
Twenty-three patients have undergone neuroembolization
procedures at Henry Ford Hospital from 1981 through 1985. AU
procedures were performed by one of the authors (Mehta) in the
Department of Radiology, Division of Neuroradiology. These
23 patients can be conveniently grouped into four categories
based on the therapeutic goal of the interventional procedure and
the underlying pathology.
Preoperative tumor embolization—Eighteen patients underwent preoperative particulate embolization for devascularization
of head, neck, and spine tumors. Patients' ages ranged from 5 to
74.
Tumor blood supply derived from external carotid artery
branches was successfully embolized in five patients with meningioma (Fig 1), one with a temporal malignant fibrous
histiocytoma, and one with a gliosarcoma (Fig 2). The arterial

Fig 1(A)—A 60-year-old woman with a large left frontal
meningioma; Computed tomography (CT) scan.

Fig 1(B)—A 60-year-old woman with a large left frontal
meningioma; Preembolization left external carotid artery
injection late venous phase demonstrating diffuse tumor stain
(arrow).
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Fig 1(C)—A 60-year-old woman with a large left frontal
meningioma; Postembolization left external carotid artery
injection demonstrating obliteration ofthe tumor vascular stain
with preservation ofthe main external carotid arterial trunks.
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supply (intercostal arterial branches) to a metastatic hypernephroma involving the T3 vertebral body was also successfully
embolized (Fig 3).
Embolization was successfully performed in five patients
with juvenile nasopharyngeal angiofibroma (Fig 4), three with
glomus tympanicum (Fig 5), one with glomus jugulare, and one
with a carotid body tumor
A sluny of Gelfoam particles (UpJohn, Kalamazoo, MI) was
the embolic agent used in all 18 cases. Devascularization of the
extraaxial blood supply to the tumor was achieved in all cases
and no neurologic complications were encountered. All patients
had surgery within 24 hours. In all 18 cases, preoperative tumor
devascularization decreased blood loss during surgery and enabled the surgeon to achieve a more complete and less complicated tumor resection.
Tumor embolization without surgery—A patient with a single
tumor was treated with embolization and radiation therapy without surgery. This elderly man had a highly aggressive metastatic
hypernephroma to the osseous structures comprising the craniocervical junction. This unresectable metastasis had rapidly
destroyed the Cl vertebral body, part of C2, and the foramen
magnum, which resulted in marked craniovertebral instabUity.
Each ofthe three ECA branches feeding the tumor mass was superselectively catheterized by femoral approach and injected
with 1 mL of dehydrated ethyl alcohol (Abbott Laboratories,
Chicago, IL) (Fig 6). This resulted in complete ablation of tumor
vascularity and immediate pain control without neurologic complication. The patient eventually died of unrelated problems.
Preoperative arteriovenous malformation embolization—
The extraaxial blood supply was embolized preoperatively in
three patients with head and neck arteriovenous malformations,
without neurologic complication. Embolization resulted in facUitation of the ultimate surgical resection in each case.

Fig 2(A)—A 55-year-old woman with a left frontotemporal
gliosarcoma; CT scan.
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A 29-year-old man had a facial AVM, a cirsoid aneurysm of
the scalp, involving the forehead, with both ECA and
ophthalmic artery supply. The ECA supply was successfully
embolized with polyvinyl alcohol sponge (PVA) (Unipoint Ind.,
Highpoint, NC). This resulted in immediate and marked improvement in what had been a significant cosmetic facial deformity (Fig 7).
A 34-year-old woman had recent intracranial hemonhage and
dense left hemiparesis from a known high-flow right frontal
AVM. This huge AVM had both intraaxial and exti-aaxial supply. The latter arose from branches of the external carotid arteries bilaterally. The ECA branches supplying the AVM were
embolized bilaterally with PVA, resulting in reduced ECA flow
and facilitation of the AVM resection (Fig 8).
A 48-year-old woman had a sudden onset ofrighthemiplegia
and aphasia due to intracerebral hemonhage. Angiography revealed a dural AVM along the left tentorial leaf which drained
into the vein of Galen. The ECA branches were embolized with
several Giantro coils (Cook, Bloomington, IN), which resulted
in facilitation of surgical resection.

il

Fig 2(B)—A 55-year-old woman with a left frontotemporal
gliosarcoma. Lateral view; preembolization left external
carotid artery injection shows extraaxial tumor supply (arrow).
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Arteriovenous malformation embolization without surgery—
A single AVM patient was treated with embolization alone without surgery. She had a subjectively intolerable intracranial brait
due to a large dural AVM of the right transverse sinus and was
deemed a nonsurgical candidate due to advanced age (85) and
the extensiveness of the lesion. Embolization without surgery
was felt to be the safest therapeutic altemative for this patient.
The ECA branches supplying this lesion were embolized with
PVA, which resulted in nearly complete but temporary angiographic occlusion and cessation of symptoms. The symptoms, however, recuned at 48 hours, and the patient refused further angiography which would have provided an understanding
ofthe recunent symptoms and treatment options. No neurologic
complication was encountered (Fig 9).

Discussion
In recent years, percutaneous transcatheter embolization has
played an increasingly important role in the management of
AVMs and vascular tumors of the head, neck, and spine (2-4,9).
The goals, risks, and technique of embolizing vascular head,
neck, and spine tumors are essentially identical to those for embolizing AVMs.

Fig 2(C)—A 55-year-old woman with a left frontotemporal
gliosarcoma. Lateral view;postembolization
left external
carotid injection demonstrating patient's main external carotid
artery trunks with obliteration ofthe tumor vascular stain.

Anatomic considerations
The normal blood supply of head and neck stmcmres is categorized as either intraaxial, extraaxial, or both. Intraaxial supply consists of intemal carotid artery (ICA) and basilar artery
branches which supply brain parenchyma. Extraaxial supply

Fig 3(A)—Postmetrizamide myelogram CT in a 58-year-old
man with metastatic hypernephroma to the right side ofthe T3
vertebral body (larger arrow) with partial effacement ofthe
metrizamide fllled subarachnoid space (smaller arrow).

Fig 3(B)—Preembolization injection ofthe right supreme
intercostal artery demonstrating tumor vascular stain (arrow).
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consists of extemal carotid artery (ECA) branches and specific
small branches of the ICA and vertebral artery which supply
nonbrain tissue, eg, skin, bone, dura, etc. (13). The extraaxial
blood supply of head and neck lesions can be embolized without
damage to neurologic tissue.
In the spine, branches of the intercostal arteries (radiculomedullary branches) which supply normal spinal cord
tissue (most notably the artery of Adamkiewicz) should not be
embolized. The arterial supply to bone and paraspinal soft tissue
can be embolized.
The most important guideline in all embolization procedures
is to achieve selective deposition of particulate embolic material
in abnormal tissue while sparing normal tissue (13). This is particularly critical in head, neck, and spine embolization procedures where accidental embolization of the central nervous
system could cause a devastating neurologic deficit. Knowledge
of primary and collateral vascular pathways to the brain, cranial
nerves, and spinal cord is essential.

A" X

Fig 3(C)—Postembolization injection of the right supreme
intercostal demonstrating obliteration of tumor vascular stain.

Fig 4(A)—CT scan of a 14-year-old boy with a large right-sided
juvenile nasopharyngeal angioflbroma (arrow).
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Eig 4(B)—Preembolization. Lateral view right external carotid
injection showing intense tumor vascular stain.
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Fig 4(C)—Postembolization
devascularization.

injection

showing

tumor

Fig 5(A)—A 56-year-old man with a right-sided glomus
tympanicum. Preembolization; lateral view right common
carotid injection showing obliteration of tumor vascular stain
(arrow).
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Fig 5(B)—A 56-year-old man with a right-sided glomus
tympanicum. Postembolization; lateral view right common
carotid injection shewing obliteration of tumor vascular stain
(arrow).

Eig 6(A)—Postmetrizamide myelogram CT of a 78-year-old
man with metastatic hypernephroma destroying the body ofthe
CI vertebral body (arrow).
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Fig 6(B)—Lateral view; preembolization right common carotid
artery injection showing obliteration of tumor vascular stain
involving Cl vertebral body and surrounding soft tissues.

Eig 6(C)—Lateral view; postembolization right common
carotid artery injection showing obliteration of tumor vascular
stain involving CI vertebral body and surrounding soft tissues.

r

Fig 7(A)—A 29-year-old man with a facial AVM of the scalp.
Lateral view; preembolization left external carotid injection
arterial phase showing arterial supply from ECA branches as
well as the AVM nidus (arrow).
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Fig 7(B)—A 29-year-old man with a facial AVM of the scalp.
Venous phase of Fig 7(A) injection lateral film showing large
scalp vein draining the AVM (arrow).
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Fig 7(C)—A 29-year-old man with a facial AVM of the scalp.
Postembolization; lateral view. Left external carotid injection
showing obliteration ofthe ECA supply to the AVM.

Fig 8(A)—A 34-year-old woman with a huge right frontal AVM
with both intraaxial and extraaxial supply. Lateral view; right
ICA injection showing intraaxial supply to AVM.

Fig 7(D)—A 29-year-old man with a facial AVM of the scalp.
Postembolization; lateral view. Left internal carotid injection
showing residual ICA AVM supply from the ophthalmic artery
which could not be embolized.

Fig 8(B)—A 34-year-old woman with a huge right frontal AVM
with both intraaxial and extraaxial supply. Preembolization
left selective middle meningeal artery injection showing
obliteration ofthis extraaxial feeder.
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Fig 8(C)—A 34-year-old woman with a huge rightfrontalAVM
with both intraaxial and extraaxial supply. Postembolization left
selective middle meningeal artery injection
showing
obliteration ofthis extraaxial feeder.

Fig 8(E)—A 34-year-old woman with a huge right frontal AVM
with both intraaxial and extraaxial supply. Postembolization left
selective superficial temporal artery.

Fig 8(D)—A 34-year-old woman with a huge right frontal AVM
with both intraaxial and extraaxial .supply. Preembolization left
selective superficial temporal artery.

Fig 9(A)—An 85-year-old woman with a large inoperable dural
AVM ofthe right transverse sinus. Postembolization; lateral
view. Selective right MMA injection showing devascularization
ofthe arterial rete (arrow) which had supplied the AVM nidus.
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The goal of preoperative AVM embolization as well as embolotherapy without surgery is lesion devascularization. The pathology in an AVM lies at the capillary level where abnormal
arterial-to-venous shunting channels exist. To devascularize an
AVM, occlusive embolic material must be deposited at the capillary level. This is done by injecting emboli into the abnormal
feeding artery and letting the flow cany emboli to the abnormal
shunt site where it will lodge and result in progressive occlusion
of shunt channels (2,3,11,13).

Eig 9(B)—An 85-year-old woman with a large inoperable dural
AVM of the right transverse sinus. Preembolization; selective
percutaneous needle (smaller arrow) puncture of the right
occipital artery (larger arrow) from which a rete of small
arterial feeders supply the dural AVM nidus (hollow arrow).

Goals
Tumor embolization—The goal of preoperative embolization
of head, neck, and spine tumors is tumor devascularization. Selective deposition of embolic material within the capillary bed of
a tumor can promote thrombosis within the tumor vascular bed.
This greatly facilitates surgical resection primarily by decreasing bleeding during surgery. In addition to devascularization,
preoperative embolization may shrink the tumor In many cases
preoperative embolization may make complete or more complete tumor resection possible (2,8,13). Hospital stays are shortened and the need for transfusion and its attendant risks are
diminished. Preoperative embolization is helpful in patients
who refuse transfusion for personal or religious reasons. This
beneficial aspect of preoperative embolization may become increasingly important if concern about the safety of random donor blood product transfusion continues to increase. To prevent
revascularization of tumors from adjacent collateral sources, as
would occur with AVMs, surgery should be performed after tumor embolization whenever possible.
Embolization can be an essential part of a combined (with
chemotherapy and postembolization radiation therapy) palliative therapeutic approach to unresectable tumors. Devascularization by embolization has been shown to inhibit tumor
growth and aid pain control (2,14,15).
AVM embolization—A variety of therapeutic approaches to
head and neck AVMs have been reported (surgery alone, radiation therapy, injection of sclerosing agents, and systemic
steroids) (9). Surgical resection of facial AVMs is often technically difficult. Current controversy centers on whether surgery alone, embolization alone, or a combined approach will
yield the best results.
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Risks
Damage to nonnal neurologic tissue due to inadvertent embolization is the most seriousriskassociated with head, neck, and
spine embolization procedures. Three different mechanisms
may giveriseto neurologic deficit during embolization:
1. Reflux of embolic material from the ECA around the carotid bifurcation into the ICA circulation. This can be avoided
by using a slow hand injection technique (under fluoroscopic
guidance) so as not to elevate the pressure in the ECA vessel
being embolized (13). The risk of reflux increases as the end
point is approached due to increasing stasis in the artery being
embolized (8). Liberal use of DSA testransto carefully monitor
approach to the end point also will reduce the possibility of
reflux.
2. Passage of embolic material through normally present
extraaxial to intraaxial collateral channels may also produce
stroke. An example of this type of normal communication is
anastomoses between the occipital and vertebral artery at the Cl
level. Knowledge of the anastomotic pathways and careful attention to their possible presence on the preembolization angiogram is a must. Superselective placement of the catheter tip
beyond these communications will greatly reduce the risk of
stroke by this means (13,16).
3. The blood supply to the extracranial portions of most cranial nerves is derived from ECA branches. Palsy of the 2nd and
3rd division ofthe trigeminal nerve and cranial nerve 7 has been
reported following embolization of the middle meningeal artery
(MMA). Palsy of cranial nerves 3, 4, 6, and 5 (first division)
have been reported following embolization of normal variants of
the MMA. Embolization of the neuromeningeal branch of the
ascending pharyngeal artery can result in cranial nerve 7, 9, 10,
11, and 12 palsy (8,17). These cranial nerve palsies nearly always
resolve in less than one year. A positive test injection of lidocaine into the artery to be embolized prior to embolization wUl
alert the neuroangiographer to this potential complication.
Skin necrosis has been reported when too forceful an injection of fine particulate embolic material is employed (13).
Complications which are seen in most cases include postembolization fever and local pain. These are easily treated with preprocedural and postprocedural steroids and analgesics. The
symptoms nearly always resolve within days.

Technical considerations
Technical procedures are frequently long and tiring for both
the angiographer and patient and may require several sittings before ideal results are achieved. The use of DSA has proved to be
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an incalculable asset during these procedures. By providing instant angiographic feedback with subti-action, DSA greatly decreases the length of the procedure, the attendant's discomfort,
and fatigue of both patient and angiographer. DSA also has
made possible the practice of multiple testransduring the procedure for meticulous monitoring of progress toward end pxiint.
Prior to the availability of DSA, this practice while desirable
from a safety standpoint was not realistic.
A wide variety of embolic agents have been made available in
recent years. Particulate embolizations reported herein were performed with one of two compounds, either Gelfoam or PVA.
Gelfoam is a temporary vascular occlusive agent. The material
is degraded by proteolytic enzymatic pathways. The dissolution
of the intravascular thrombus it produces begins 24 hours after
embolization (6). Therefore, this material is used only for preoperative embolization. For optimum hemostatic effect, surgery
should be performed within 24 hours of embolization (6). The
key advantage of this material is ease of handling. Due to low
viscosity, a Gelfoam sluny will flow smoothly through the
caflieter, allowing conti-olled physiologic embolization (6,13).
An additional advantage is that normal vessels inadvertently embolized will eventually recanalize due to the temporary nature of
this occlusive material.
Conversely, PVA is a permanent occlusive agent. PVA particles serve as a "scaffolding" which promotes the ingrowth of
fibroblasts (5,6). Thisfibroblasticproliferation results in permanent vascular occlusion, with PVA an "integral" part of the
body (5,6,18). PVA is used if surgery is not planned immediately or at all. The disadvantage of PVA is that it is more difficult
to handle. A sluny of PVA particles is very viscous (5,6). Therefore, it is difficult to achieve a smooth, controlled introduction
through the catheter and the risk of inadvertent embolization of
normal vessels is higher Also, accidental embolization of normal vessels will be permanent.
Transcatheter embolization of an unresectable metastasis to
the craniocervical region was performed with ethanol in one patient. Ethanol has been shown in animal studies to be an excellent neurovascular sclerosing agent. When perfused directly into
the middle cerebral artery of monkeys, focal segmental vascular
sclerosis is produced with no distal endothelial injury and no
seizure activity (19). Ethanol fulfills all the requirements ofan
ideal vascular occlusive agent: low viscosity, nonadhesive, inexpensive, readily available, and easy to sterilize (19).
Ethanol has been proven effective in human use for ablation
of renal cell carcinoma (14). Used in this setting, it produces
complete tumor necrosis and permanent arterial occlusion. This
was the effect desired in the patient with end stage metastatic
disease to the craniocervical junction. The mechanism of action
appears to be direct cellular damage to the endothelium which is
followed later by thrombosis (14,15).
The one dural AVM embolized with intravascular coils was
performed early in our embolization experience. This technique
results in arterial occlusion proximal to the AVM nidus and
would not be our method of choice today (13).
Much remains unknown in the field of therapeutic neuroembolization. Initial vascular occlusion postembolization depends
on a variety of factors including particle size, thrombogenicity
of embolic material, the method of injection (selectively and
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control of blood flow), and hemodynamic characteristics of the
lesion to be embolized. The precise interrelationship of these
variables wanants further study (3,6,13). Littie is known about
embolization dynamics. The status of the embolized vascular
bed changesflu-oughoutan embolization procedure. The relative roles of vessel spasm, thrombosis, and histologic reaction of
the vessel wall in producing vascular occlusion need to be evaluated (3,6,13).

Summary
Therapeutic embolization techniques can be applied to a variety of vascular lesions of the head, neck, and spine. Our experience with these procedures has been summarized in four broad
categories: preoperative tumor embolization, tumor embolization without surgery, preoperative arteriovenous malformation
embolization, and arteriovenous malformation embolization
without surgery. With careful attention to technique, these procedures can be performed with minimal risk and with excellent
therapeutic results. This is a rapidly changing field with many
areas of active research. A broad range of clinical specialists
should be aware of these techniques, as potential embolization
candidates may be seen in many different clinical specialty
areas.
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